12 Best Drug Stocks to Buy Right Now

Page 7 of 11

5. Pfizer Inc. (NYSE:PFE)

Number of Hedge Fund Holders: 83

Pfizer Inc. (NYSE:PFE) is one of the best drug stocks to buy right now. In a report released on September 5, Vamil Divan from Guggenheim maintained a Buy rating on Pfizer Inc. (NYSE:PFE), setting a price target of $33.00.

In other news, Pfizer Inc. (NYSE:PFE) and BioNTech SE announced on September 8 positive topline results from an ongoing Phase 3 clinical trial cohort “evaluating the safety, tolerability, and immunogenicity of a 30-µg dose of the LP.8.1-adapted monovalent COMIRNATY® 2025-2026 Formula in adults aged 65 and older and in adults aged 18 through 64 with at least one underlying risk condition for severe COVID-19.”

Management reported that the preliminary data exhibited considerable growth in neutralizing antibodies targeting the LP.8.1 sublineage of SARS-CoV-2 after the vaccination, reinforcing pre-clinical data that supported the recent U.S. Food and Drug Administration (FDA) approval of the LP.8.1-adapted COVID-19 vaccine demonstrating improved immune responses against multiple circulating SARS-CoV-2 sublineages.

Pfizer Inc. (NYSE:PFE) also reported that the vaccine’s safety profile was consistent with previous studies, and no new safety concerns were identified.

Pfizer Inc. (NYSE:PFE) is a global biopharmaceutical company that manufactures, develops, markets, and sells biopharmaceutical products worldwide. It advances wellness, prevention, treatment, and cures in developing and emerging markets.

Page 7 of 11